Poseida Therapeutics (PSTX) just unveiled an update.
Brent Warner has announced his resignation as President of Gene Therapy at the Company, effective April 1, 2024, in order to take on a new career opportunity elsewhere. This move could signal a shift within the company and is of interest to those tracking leadership changes in the financial markets.
See more insights into PSTX stock on TipRanks’ Stock Analysis page.
